Real-time enrollment status for this relapsed adult acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:02 PM UTC
| NCT Number | NCT06472128 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Adult Acute Myeloid Leukemia |
| Phase | Clinical Trial |
| Target Enrollment | 200 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Massachusetts General Hospital |
| Last Updated on CT.gov | November 10, 2025 (Nov 10, 2025) |
As of July 13, 2026: Clinical trial NCT06472128 is currently recruiting participants. This clinical trial study for relapsed adult acute myeloid leukemia is actively seeking new participants at 3 locations across the United States. The study is sponsored by Massachusetts General Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06472128 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06472128 was last updated Nov 10, 2025 (November 10, 2025). HelloStudys verifies this status automatically.